Clinical Trials Directory

Trials / Completed

CompletedNCT05232799

Care Anywhere With Community Paramedics Program to Reduce Hospitalization

Community Paramedic Hospitalization Reduction and Mitigation Program: Pragmatic Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
250 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to compare the effectiveness of the Care Anywhere with Community Paramedics program with usual care in a pragmatic randomized controlled trial. The goal of the Care Anywhere with Community Paramedics program is to prevent or shorten hospitalizations among patients who are being treated in the clinic/ambulatory setting ("prehospital setting"), emergency department, or hospital and are clinically appropriate to be cared for at home with community paramedic services.

Detailed description

This pragmatic randomized controlled trial will randomize, with 1:1 allocation, 240 adults being treated in the pre-hospital setting, emergency department or hospital to either availability of the Care Anywhere with Community Paramedics (CACP) program or to no availability of the CACP program (i.e. usual care). Patients randomized to the CACP program will be able to receive in-home medical care - as ordered by their treating clinicians - from the Mayo Clinic Ambulance Community Paramedic Service. Primary outcome is going to be days alive spent at home without hospitalization (excluding planned admissions), emergency department visits, or skilled nursing facility care.

Conditions

Interventions

TypeNameDescription
OTHERCare Anywhere with Community Paramedics programOutpatient management with supportive services provided by the community paramedic team.

Timeline

Start date
2022-01-21
Primary completion
2023-03-31
Completion
2023-03-31
First posted
2022-02-10
Last updated
2023-10-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05232799. Inclusion in this directory is not an endorsement.